Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5,169,697
-
Total 13F shares
-
675,140
-
Share change
-
-301,440
-
Total reported value
-
$7,332,178
-
Price per share
-
$10.86
-
Number of holders
-
9
-
Value change
-
-$3,254,170
-
Number of buys
-
2
-
Number of sells
-
6
Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q3 2023
As of 30 Sep 2023 CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 675,140 shares of stock of the company.
Largest 9 holders included METEORA CAPITAL, LLC, Mint Tower Capital Management B.V., Yakira Capital Management, Inc., CLEAR STREET LLC, Shaolin Capital Management LLC, Walleye Capital LLC, BERKLEY W R CORP, Walleye Trading LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 9 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.